Loading…

Inhibition of denervation changes in skeletal muscle by blockers of protein synthesis

1. A study was made of the effects of inhibitors of protein synthesis (actinomycin D, chloramphenicol and cycloheximide) on the in vivo development of extrajunctional cholinergic receptors, tetrodotoxin-resistant action potentials, slowing of the time course of the action potential, and on the fall...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of physiology 1972-03, Vol.221 (3), p.743-754
Main Authors: Grampp, W., Harris, J. B., Thesleff, S.
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c5993-29e217057e313f862f7b4bb6f3679b95b123c0940d30944d50154b7249ed07943
cites
container_end_page 754
container_issue 3
container_start_page 743
container_title The Journal of physiology
container_volume 221
creator Grampp, W.
Harris, J. B.
Thesleff, S.
description 1. A study was made of the effects of inhibitors of protein synthesis (actinomycin D, chloramphenicol and cycloheximide) on the in vivo development of extrajunctional cholinergic receptors, tetrodotoxin-resistant action potentials, slowing of the time course of the action potential, and on the fall in the resting membrane potential in denervated mouse skeletal muscle. 2. Actinomycin D (0·5 mg/kg, I.P. ) reduced the incorporation of uridine into skeletal muscle by 50-60% for 4-5 days. There was no simultaneous reduction in L -leucine incorporation. 3. Actinomycin D (0·5 mg/kg I.P. , 1 day after denervation) inhibited the development of extrajunctional cholinergic receptors, tetrodotoxin-resistant action potentials and the fall in resting membrane potential for approximately 4 days. 4. The post-denervation fall in the maximum rate of rise and in the amplitude of the overshoot of the muscle fibre action potential was unaffected by actinomycin D treatment. 5. Actinomycin D failed to inhibit the appearance of the membrane changes if given later than 2 days after denervation. 6. Chloramphenicol (6 g/kg in divided doses) and cycloheximide (40 g/kg every 12 hr) were also able to inhibit the appearance of the membrane changes. 7. It is concluded that some denervation induced changes in the muscle fibre membrane depend on the synthesis of new proteins. The results imply that the motor nerve cell normally exerts a regulatory influence on the genome of the muscle cell.
doi_str_mv 10.1113/jphysiol.1972.sp009780
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1331364</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1694975316</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5993-29e217057e313f862f7b4bb6f3679b95b123c0940d30944d50154b7249ed07943</originalsourceid><addsrcrecordid>eNqNkUtP3DAUha2qiE6n_Qmtsms3GfxKjDdIFLU8hAQLWFuxczMxeOxgZ0D5903IgGDHyrLPOd-98kHoJ8ErQgg7uOvaIdngVkQKukodxlIc4k9oQXgpcyEk-4wWGFOaM1GQL-hrSncYE4al3Ef7BSYlE3iBbs99a7XtbfBZaLIaPMTH6vlq2sqvIWXWZ-keHPSVyzbbZBxkesi0C-YeYppSXQw9TLbB9y0km76hvaZyCb7vziW6_ff35uQsv7w6PT85vsxNISXLqQRKBC4EMMKaw5I2QnOty4aVQmpZaEKZwZLjelyb83rcuuBaUC6hxkJytkRHM7fb6g3UBnwfK6e6aDdVHFSorHqveNuqdXhUhI0TywnweweI4WELqVcbmww4V3kI26RIKbkUBRt_a4nK2WpiSClC8zqGYDVVol4qUVMl6qWSMfjj7ZKvsV0Ho_5n1p-sg-GDVHVzcT09UEqY4GyE_JohrV23TzaCmmMpGAv9oEafYmpy_gcGGK5D</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1694975316</pqid></control><display><type>article</type><title>Inhibition of denervation changes in skeletal muscle by blockers of protein synthesis</title><source>PubMed Central</source><creator>Grampp, W. ; Harris, J. B. ; Thesleff, S.</creator><creatorcontrib>Grampp, W. ; Harris, J. B. ; Thesleff, S.</creatorcontrib><description>1. A study was made of the effects of inhibitors of protein synthesis (actinomycin D, chloramphenicol and cycloheximide) on the in vivo development of extrajunctional cholinergic receptors, tetrodotoxin-resistant action potentials, slowing of the time course of the action potential, and on the fall in the resting membrane potential in denervated mouse skeletal muscle. 2. Actinomycin D (0·5 mg/kg, I.P. ) reduced the incorporation of uridine into skeletal muscle by 50-60% for 4-5 days. There was no simultaneous reduction in L -leucine incorporation. 3. Actinomycin D (0·5 mg/kg I.P. , 1 day after denervation) inhibited the development of extrajunctional cholinergic receptors, tetrodotoxin-resistant action potentials and the fall in resting membrane potential for approximately 4 days. 4. The post-denervation fall in the maximum rate of rise and in the amplitude of the overshoot of the muscle fibre action potential was unaffected by actinomycin D treatment. 5. Actinomycin D failed to inhibit the appearance of the membrane changes if given later than 2 days after denervation. 6. Chloramphenicol (6 g/kg in divided doses) and cycloheximide (40 g/kg every 12 hr) were also able to inhibit the appearance of the membrane changes. 7. It is concluded that some denervation induced changes in the muscle fibre membrane depend on the synthesis of new proteins. The results imply that the motor nerve cell normally exerts a regulatory influence on the genome of the muscle cell.</description><identifier>ISSN: 0022-3751</identifier><identifier>EISSN: 1469-7793</identifier><identifier>DOI: 10.1113/jphysiol.1972.sp009780</identifier><identifier>PMID: 5016370</identifier><language>eng</language><publisher>England: The Physiological Society</publisher><subject>Action Potentials - drug effects ; Animals ; Chloramphenicol - pharmacology ; Cycloheximide - pharmacology ; Dactinomycin - pharmacology ; Leucine - metabolism ; Male ; Membrane Potentials - drug effects ; Metabolism ; Mice ; Muscle Denervation ; Muscle Proteins - biosynthesis ; Muscles - drug effects ; Muscles - innervation ; Muscles - metabolism ; Muscles - physiology ; Receptors, Cholinergic ; RNA - biosynthesis ; Tetrodotoxin - pharmacology ; Time Factors ; Uridine - metabolism</subject><ispartof>The Journal of physiology, 1972-03, Vol.221 (3), p.743-754</ispartof><rights>1972 The Physiological Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5993-29e217057e313f862f7b4bb6f3679b95b123c0940d30944d50154b7249ed07943</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1331364/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1331364/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/5016370$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Grampp, W.</creatorcontrib><creatorcontrib>Harris, J. B.</creatorcontrib><creatorcontrib>Thesleff, S.</creatorcontrib><title>Inhibition of denervation changes in skeletal muscle by blockers of protein synthesis</title><title>The Journal of physiology</title><addtitle>J Physiol</addtitle><description>1. A study was made of the effects of inhibitors of protein synthesis (actinomycin D, chloramphenicol and cycloheximide) on the in vivo development of extrajunctional cholinergic receptors, tetrodotoxin-resistant action potentials, slowing of the time course of the action potential, and on the fall in the resting membrane potential in denervated mouse skeletal muscle. 2. Actinomycin D (0·5 mg/kg, I.P. ) reduced the incorporation of uridine into skeletal muscle by 50-60% for 4-5 days. There was no simultaneous reduction in L -leucine incorporation. 3. Actinomycin D (0·5 mg/kg I.P. , 1 day after denervation) inhibited the development of extrajunctional cholinergic receptors, tetrodotoxin-resistant action potentials and the fall in resting membrane potential for approximately 4 days. 4. The post-denervation fall in the maximum rate of rise and in the amplitude of the overshoot of the muscle fibre action potential was unaffected by actinomycin D treatment. 5. Actinomycin D failed to inhibit the appearance of the membrane changes if given later than 2 days after denervation. 6. Chloramphenicol (6 g/kg in divided doses) and cycloheximide (40 g/kg every 12 hr) were also able to inhibit the appearance of the membrane changes. 7. It is concluded that some denervation induced changes in the muscle fibre membrane depend on the synthesis of new proteins. The results imply that the motor nerve cell normally exerts a regulatory influence on the genome of the muscle cell.</description><subject>Action Potentials - drug effects</subject><subject>Animals</subject><subject>Chloramphenicol - pharmacology</subject><subject>Cycloheximide - pharmacology</subject><subject>Dactinomycin - pharmacology</subject><subject>Leucine - metabolism</subject><subject>Male</subject><subject>Membrane Potentials - drug effects</subject><subject>Metabolism</subject><subject>Mice</subject><subject>Muscle Denervation</subject><subject>Muscle Proteins - biosynthesis</subject><subject>Muscles - drug effects</subject><subject>Muscles - innervation</subject><subject>Muscles - metabolism</subject><subject>Muscles - physiology</subject><subject>Receptors, Cholinergic</subject><subject>RNA - biosynthesis</subject><subject>Tetrodotoxin - pharmacology</subject><subject>Time Factors</subject><subject>Uridine - metabolism</subject><issn>0022-3751</issn><issn>1469-7793</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1972</creationdate><recordtype>article</recordtype><recordid>eNqNkUtP3DAUha2qiE6n_Qmtsms3GfxKjDdIFLU8hAQLWFuxczMxeOxgZ0D5903IgGDHyrLPOd-98kHoJ8ErQgg7uOvaIdngVkQKukodxlIc4k9oQXgpcyEk-4wWGFOaM1GQL-hrSncYE4al3Ef7BSYlE3iBbs99a7XtbfBZaLIaPMTH6vlq2sqvIWXWZ-keHPSVyzbbZBxkesi0C-YeYppSXQw9TLbB9y0km76hvaZyCb7vziW6_ff35uQsv7w6PT85vsxNISXLqQRKBC4EMMKaw5I2QnOty4aVQmpZaEKZwZLjelyb83rcuuBaUC6hxkJytkRHM7fb6g3UBnwfK6e6aDdVHFSorHqveNuqdXhUhI0TywnweweI4WELqVcbmww4V3kI26RIKbkUBRt_a4nK2WpiSClC8zqGYDVVol4qUVMl6qWSMfjj7ZKvsV0Ho_5n1p-sg-GDVHVzcT09UEqY4GyE_JohrV23TzaCmmMpGAv9oEafYmpy_gcGGK5D</recordid><startdate>19720301</startdate><enddate>19720301</enddate><creator>Grampp, W.</creator><creator>Harris, J. B.</creator><creator>Thesleff, S.</creator><general>The Physiological Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>5PM</scope></search><sort><creationdate>19720301</creationdate><title>Inhibition of denervation changes in skeletal muscle by blockers of protein synthesis</title><author>Grampp, W. ; Harris, J. B. ; Thesleff, S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5993-29e217057e313f862f7b4bb6f3679b95b123c0940d30944d50154b7249ed07943</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1972</creationdate><topic>Action Potentials - drug effects</topic><topic>Animals</topic><topic>Chloramphenicol - pharmacology</topic><topic>Cycloheximide - pharmacology</topic><topic>Dactinomycin - pharmacology</topic><topic>Leucine - metabolism</topic><topic>Male</topic><topic>Membrane Potentials - drug effects</topic><topic>Metabolism</topic><topic>Mice</topic><topic>Muscle Denervation</topic><topic>Muscle Proteins - biosynthesis</topic><topic>Muscles - drug effects</topic><topic>Muscles - innervation</topic><topic>Muscles - metabolism</topic><topic>Muscles - physiology</topic><topic>Receptors, Cholinergic</topic><topic>RNA - biosynthesis</topic><topic>Tetrodotoxin - pharmacology</topic><topic>Time Factors</topic><topic>Uridine - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Grampp, W.</creatorcontrib><creatorcontrib>Harris, J. B.</creatorcontrib><creatorcontrib>Thesleff, S.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Journal of physiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Grampp, W.</au><au>Harris, J. B.</au><au>Thesleff, S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Inhibition of denervation changes in skeletal muscle by blockers of protein synthesis</atitle><jtitle>The Journal of physiology</jtitle><addtitle>J Physiol</addtitle><date>1972-03-01</date><risdate>1972</risdate><volume>221</volume><issue>3</issue><spage>743</spage><epage>754</epage><pages>743-754</pages><issn>0022-3751</issn><eissn>1469-7793</eissn><abstract>1. A study was made of the effects of inhibitors of protein synthesis (actinomycin D, chloramphenicol and cycloheximide) on the in vivo development of extrajunctional cholinergic receptors, tetrodotoxin-resistant action potentials, slowing of the time course of the action potential, and on the fall in the resting membrane potential in denervated mouse skeletal muscle. 2. Actinomycin D (0·5 mg/kg, I.P. ) reduced the incorporation of uridine into skeletal muscle by 50-60% for 4-5 days. There was no simultaneous reduction in L -leucine incorporation. 3. Actinomycin D (0·5 mg/kg I.P. , 1 day after denervation) inhibited the development of extrajunctional cholinergic receptors, tetrodotoxin-resistant action potentials and the fall in resting membrane potential for approximately 4 days. 4. The post-denervation fall in the maximum rate of rise and in the amplitude of the overshoot of the muscle fibre action potential was unaffected by actinomycin D treatment. 5. Actinomycin D failed to inhibit the appearance of the membrane changes if given later than 2 days after denervation. 6. Chloramphenicol (6 g/kg in divided doses) and cycloheximide (40 g/kg every 12 hr) were also able to inhibit the appearance of the membrane changes. 7. It is concluded that some denervation induced changes in the muscle fibre membrane depend on the synthesis of new proteins. The results imply that the motor nerve cell normally exerts a regulatory influence on the genome of the muscle cell.</abstract><cop>England</cop><pub>The Physiological Society</pub><pmid>5016370</pmid><doi>10.1113/jphysiol.1972.sp009780</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-3751
ispartof The Journal of physiology, 1972-03, Vol.221 (3), p.743-754
issn 0022-3751
1469-7793
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1331364
source PubMed Central
subjects Action Potentials - drug effects
Animals
Chloramphenicol - pharmacology
Cycloheximide - pharmacology
Dactinomycin - pharmacology
Leucine - metabolism
Male
Membrane Potentials - drug effects
Metabolism
Mice
Muscle Denervation
Muscle Proteins - biosynthesis
Muscles - drug effects
Muscles - innervation
Muscles - metabolism
Muscles - physiology
Receptors, Cholinergic
RNA - biosynthesis
Tetrodotoxin - pharmacology
Time Factors
Uridine - metabolism
title Inhibition of denervation changes in skeletal muscle by blockers of protein synthesis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T23%3A26%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Inhibition%20of%20denervation%20changes%20in%20skeletal%20muscle%20by%20blockers%20of%20protein%20synthesis&rft.jtitle=The%20Journal%20of%20physiology&rft.au=Grampp,%20W.&rft.date=1972-03-01&rft.volume=221&rft.issue=3&rft.spage=743&rft.epage=754&rft.pages=743-754&rft.issn=0022-3751&rft.eissn=1469-7793&rft_id=info:doi/10.1113/jphysiol.1972.sp009780&rft_dat=%3Cproquest_pubme%3E1694975316%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5993-29e217057e313f862f7b4bb6f3679b95b123c0940d30944d50154b7249ed07943%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1694975316&rft_id=info:pmid/5016370&rfr_iscdi=true